Chu-Pak Lau, MD

Stable and Optimal Anticoagulation is Achieved with a Single Dose of Intravenous Enoxaparin in Patients Undergoing Percutaneous

08/01/2008

William Ng , MBBS;

Wai-Hong Chen , MBBS;

Chu-Pak Lau , MD;

Yuk-Kong Lau , MBBS;

Pui-Yin Lee , MBBS;

Cheuk-Man Yu , MD;

Edmond Ma , MD;

Unfractionated heparin (UFH) has been the anticoagulant of choice for percutaneous coronary intervention (PCI) since the procedure’s inception, although few data exist regarding the optimal extent of activated partial thromboplastin time...

Unfractionated heparin (UFH) has...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Chu-Pak Lau, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products